SEC Form 4 · accession 0001562180-18-002341
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeryl L Hilleman
Officer — Chief Financial Officer
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 3, 2018 | M | 12,833 | $11.12 | A | 36,265 | D | |
| Common StockF2 | May 3, 2018 | S | 12,833 | $39.9414 | D | 23,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $11.12 | May 3, 2018 | M | 12,833 | D | — | Jun 10, 2024 | Common Stock | 12,833 | 33,833 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.30, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F3The shares subject to the option vest commencing June 4, 2014. 25% of the shares subject to the option vested on June 4, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.